# Michelle Longmire

> Dr. Michelle Longmire is the co-founder and CEO of Medable, the leading platform for agentic AI in clinical development. A Stanford-trained physician-scientist who grew up in a Los Alamos nuclear-research family, she pivoted from dermatology to founding Medable in 2015 after hitting enrollment walls in her own clinical research. Under her leadership, Medable has raised over $500 million in venture capital, deployed its platform in roughly 400 trials across 70 countries in 120 languages, and served more than one million patients globally - transforming how the world runs clinical trials.

- **Role:** Co-Founder and CEO at Medable
- **Organizations:** Medable, Stanford University School of Medicine, Howard Hughes Medical Institute, National Cancer Institute, Los Alamos National Laboratory
- **From:** Los Alamos, New Mexico, United States
- **Nationality:** American
- **Education:** Undergraduate (Biology focus), University of New Mexico, MD (Medical Degree), Stanford University School of Medicine, Dermatology Residency, Stanford University Medical Center, Postdoctoral Research Fellowship, Stanford University School of Medicine
- **Known for:** Co-founded Medable in 2015; grew it to a $2.1 billion valuation by 2021, Raised over $500 million in venture capital for Medable, Named one of Fast Company's 100 most creative people in business

## Career timeline

- **Early life** — Grew up in Los Alamos, New Mexico in a prominent scientific family - grandfather worked on hydrogen bomb development, father was a molecular biologist on the Human Genome Project, mother a plutonium radiochemist
- **Age 14** — Began playing soccer despite late start; trained 3+ hours daily and earned a Division I scholarship to University of New Mexico within three years
- **Undergraduate** — Attended University of New Mexico on soccer scholarship, served as team captain, became a Rhodes Scholarship finalist
- **2008** — Co-founded the Community Vision Project with Dr. Linda Rose through AAMC funding
- **2010s** — Completed dermatology residency and postdoctoral fellowship at Stanford University; worked as attending physician and faculty member
- **2015** — Founded Medable while still a Stanford resident, raising $700K; identified critical barriers to clinical trial enrollment during own research on systemic sclerosis in identical twins
- **2016** — Left Stanford faculty position to focus fully on Medable; pivoted platform toward clinical trial applications after attracting $3M investment from Bob Duggan
- **2019-2020** — Company grew from 100 to 400 employees; achieved 300% revenue growth, 125% net revenue retention, and 50 new clients; remote trial capability proved critical during COVID-19 pandemic
- **2021-10** — Led Medable's $304M Series D round at $2.1B valuation, co-led by Blackstone Growth, GSR Ventures, and Tiger Global
- **2024** — Presented at J.P. Morgan Healthcare Conference; Medable platform deployed in 400+ trials across 70 countries in 120 languages
- **2026-05** — Featured as international guest speaker at Japan's Ubie Pharma Summit alongside leaders from Google and Mayo Clinic; also speaking at ASCO, Bio-IT World, and Clinical Trials Technology Congress

## Achievements

- Co-founded Medable in 2015; grew it to a $2.1 billion valuation by 2021
- Raised over $500 million in venture capital for Medable
- Named one of Fast Company's 100 most creative people in business
- Led Medable platform deployment in approximately 400 trials across 70 countries, in 120 languages, serving over 1 million patients globally
- Earned Division I soccer scholarship to University of New Mexico starting at soccer at age 14
- Rhodes Scholarship finalist
- Howard Hughes Medical Institute fellowship recipient
- Research internships at National Cancer Institute and Los Alamos National Laboratory
- Co-founded Community Vision Project (2008) with Dr. Linda Rose through AAMC funding
- Built one of the first fully remote/decentralized clinical trial platforms before COVID-19 made it essential

## Latest updates

- **2026-05** — Featured as one of three international guest speakers at Japan's Ubie Pharma Summit alongside leaders from Google Health and Mayo Clinic Platform
- **2026-05** — Medable speaking at Fierce Biotech Week, Bio-IT World Expo, Clinical Trials Technology Congress (London), and ASCO Conference
- **2026-01** — Presented at J.P. Morgan Healthcare Conference 2026; discussed AI-driven clinical trial innovation
- **2024-12** — Medable announced presentation at 43rd Annual J.P. Morgan Healthcare Conference
- **2024** — Medable platform now deployed in approximately 400 trials across 70 countries in 120 languages, serving over 1 million patients

## Links

- Website: https://medable.com
- LinkedIn: https://www.linkedin.com/in/michellelongmire
- Twitter/X: https://twitter.com/LongmireMD
- YouTube: https://www.youtube.com/watch?v=xeTrswoM7Sc
- Facebook: https://www.facebook.com/MedableInc/

---

Profile page: https://yespress.io/michelle-longmire
Published by YesPress — https://yespress.io
Last updated: 2026-05-25